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Mouse embryos lacking the retinoic acid receptor RXR properly undergo the early steps of heart development, but then fail
to initiate a proliferative expansion of cardiomyocytes that normally results in the formation of the compact zone of the
ventricular chamber wall. RXR/ embryos have a hypoplastic ventricular chamber and die in midgestation from cardiac
insufficiency. In this study, we have investigated the underlying mechanistic basis of this phenotype. We find that
interference with retinoic acid receptor function in the epicardium of transgenic embryos recapitulates the hypoplastic
phenotype of RXR deficient embryos. We further show that wild type primary epicardial cells, and an established epicardial
cell line (EMC cells), secrete trophic protein factors into conditioned media that stimulate thymidine incorporation in
primary fetal cardiomyocytes, and thymidine incorporation, cell cycle progression, and induction of cyclin D1 and E activity
in NIH3T3 cells. In contrast, primary epicardial cells derived from RXR/ embryos and an EMC subline constitutively
expressing a dominant negative receptor construct both fail to secrete activity into conditioned media. The production of
trophic factors is induced by retinoic acid treatment and is inhibited by a retinoid receptor antagonist. Fetal atrial and
ventricular myocytes both respond to epicardial-derived trophic signaling, although postnatal cardiomyocytes are nonre-
sponsive. We therefore propose that the fetal epicardium, in response to retinoic acid and in a manner requiring the activity
of RXR, secretes trophic factors which drive fetal cardiomyocyte proliferation and promote ventricular chamber
morphogenesis. © 2002 Elsevier Science (USA)INTRODUCTION
Heart development, as for most aspects of organogenesis,
requires the concerted interaction between cells of different
lineage origin in order to promote the elaboration of com-
plex structures. At least four independent primary cell
types—myocardium, endocardium and endothelium, epi-
cardium, and neural crest—contribute to the developing
heart and are responsible for its morphogenesis. The myo-
cardial and endocardial lineages are present and distinct
even before the actual formation of the heart from splanch-
nic mesoderm (Cohen-Gould and Mikawa, 1996), which in
mouse embryos, occurs at embryonic day 7.5 (E7.5). The
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198neural crest cell lineage migrates into the heart around E9.5
and is restricted to populating the outflow region of the
heart (Jiang et al., 2000). The epicardial lineage originates
from a region adjacent to the septum transversum, and
migrates over the outer surface to ultimately (by E9.5–
E10.5) surround the heart (Viragh and Challice, 1981).
Subsequent interactions between these primary cell layers
are responsible for the derivation of additional cardiac cell
types [e.g., mesenchymal cells of the endocardial cushions
are derived from the endocardium (Markwald et al., 1977),
and mesenchymal cells, which constitute the endothelium
and smooth muscle of the coronary arteries, as well as the
cardiac fibroblast lineage, are derived from the epicardium
(Mikawa, 1999)].
The fetal ventricular chamber at E9.5 is a thin-walled and
undivided structure; formation of a mature ventricular
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chamber requires two distinct proliferative and morpho-
genic processes, both of which initiate around E9.5–E10.5.
Proliferation of the myocardium on the inner (endocardial)
side of the ventricular chamber wall and the alignment of
these cells into bundles forms the trabecular layer of the
myocardium. Proliferation of the myocardium on the outer
(epicardial) side of the chamber wall, and the alignment of
these cells along the circumferential axis of the heart, forms
the compact zone of the ventricular chamber wall. En-
hanced compact zone proliferation and ingression of cardi-
omyocytes at the ventricular sulcus leads to formation of
the interventricular septum, which divides the ventricular
chamber into right and left sides. It has been suggested that
the trabecular layer accounts for a greater percentage of the
contractile force of the early heart (prior to approx. E12.5),
although thereafter, the rapidly expanding compact layer
accounts for an increasingly greater proportion of contrac-
tile strength (Sedmera and Thomas, 1996). This inference is
borne out by mouse mutants which selectively affect either
process individually, such that defects in trabecular forma-
tion result in embryo lethality around E10.5, whereas
defects in compact zone formation result in lethality
around E14.5–E16.5 (Sucov, 1998).
The signals which mediate these morphogenic processes
are of obvious interest. Retinoic acid, the bioactive form of
vitamin A, is known to be involved in compact zone
formation, as rat embryos deficient in vitamin A (Wilson
and Warkany, 1949) and mouse embryos lacking the reti-
noic acid receptor gene RXR (Sucov et al., 1994; Kastner et
al., 1994) both suffer from an inability to properly form the
compact zone. This results in a thin-walled hypoplastic
ventricular chamber with a poorly formed interventricular
septum that leads to midgestation lethality. Direct count-
ing of mitotic cells has demonstrated that this represents a
proliferative defect, and there is no indication that elevated
cell death contributes to this phenotype (Kastner et al.,
1997). Although this is ultimately a phenotype of the
myocardium, a number of approaches have demonstrated
that the myocardium does not utilize RXR to respond to
retinoic acid. Thus, tissue-specific knockout of the RXR
gene in the myocardium results in a normally formed heart
(Chen et al., 1998), individual cardiomyocytes lacking
RXR in chimeric embryos proliferate normally (Tran and
Sucov, 1998), and transgenic expression of RXR specifi-
cally in the myocardium does not rescue the defects of
RXR/ hearts (Subbarayan et al., 2000). Consequently, the
processes that are initiated by retinoic acid, and which
result in cardiomyocyte proliferation and formation of the
ventricular chamber compact zone, are inferred to be indi-
rect.
A reasonable model is that another tissue first responds
to retinoid signaling through RXR, and then in a second
step, influences myocardial proliferation. Candidate tissues
in the heart for the site of RXR action include the
endocardium, the epicardium, and the neural crest, as well
as derivatives of these primary cell types. In principle, a
tissue or process external to the heart might also be respon-
sible for the RXR/ cardiac phenotype. RXR is ubiqui-
tously expressed during early and midgestation (Dolle et al.,
1994; Mangelsdorf et al., 1992), providing no insight into its
site of action.
In this study, we have further investigated the underlying
basis of the RXR/ phenotype. We show that the epicar-
dium, in response to retinoic acid and in a manner which
requires RXR, secretes trophic factors which stimulate
cardiomyocyte proliferation and compact zone morphogen-
esis.
MATERIALS AND METHODS
Conditional and Chimeric Mouse Embryos
Embryos bearing the Wnt1-cre transgene (Jiang et al., 2000) and
homozygous for the conditional RXR allele (Chen et al., 1998)
were isolated at E14.5 or later for histological assessment of cardiac
morphogenesis. To create chimeric embryos, a previously de-
scribed RXR/ ES cell line (Tran and Sucov, 1998) was introduced
by aggregation into recipient blastocysts derived by crosses of
Flk1/ parents. Embryos were isolated at E14.5, and the genotype
of the recipient blastocyst was identified retrospectively by geno-
type determination of the visceral endoderm (Hogan et al., 1994).
Generation and Analysis of Transgenic Mice
The dominant negative human RAR clone used in these studies
(Saitou et al., 1995) carries a point mutation (G303E) that is
homologous to a point mutation in the thyroid hormone receptor
that causes generalized thyroid hormone resistance. The human
keratin 18 clone (Thorey et al., 1993) used for transgenic studies
(GenBank Accession No. AF179904) contains 2.5 kb of 5 sequence,
the entire transcribed region of the gene, and 3.5 kb of sequence 3
to the polyadenylation site. The endogenous ATG site of the K18
clone was altered by mutagenesis into a EagI site, and the RAR303E
sequence, containing a consensus translation initiation sequence,
was cloned into that site. Transgenic embryos were generated by
pronuclear injection of excised K18-RAR303E DNA and were
isolated at E14.5 for analysis. Genotyping was performed by PCR
amplification using DNA extracted from yolk sac tissue.
Epicardial Cell Culture and Conditioned Media
To derive primary epicardial cells, fetal and neonatal hearts were
dissected, cut coarsely into four to eight pieces, and plated onto
gelatin-coated dishes in DMEM/15%FBS. Epicardial cells migrate
away and form a monolayer surrounding the remaining cardiac
tissue, which after 4 days, was removed using forceps. The epicar-
dial cells were further cultured in DMEM/10%FBS, and trypsinized
for further passaging. Primary cells were expanded by passaging at
least four times without alteration in epithelial morphology. Cell
purity was assessed at single cell level by using antibodies against
pan-cytokeratin (Sigma, cat #2562), sarcomeric myosin (MF20), and
PECAM (M-20, Santa Cruz Biotechnology). For RT-PCR evalua-
tion, RNA was extracted from coarsely cut whole heart tissue or
from passaged primary epicardial cells. Following random-primed
reverse transcription, PCR amplification of the following segments
of GenBank entries was done by using standard conditions: 139-626
of NM_009022.1 (RALDH2), 456-847 of M11686 (K18), 215-551 of
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AF047418 (epicardin), 460-996 of NM_009608 (cardiac actin), 84-
545 of XM_132324 (MLC2v), 275-701 of AY056464 (MHC), 1132-
1489 of L06039 (PECAM1), and 2188-2490 of X71426.1 (Tie2).
The RAR303E construct described above was cloned into the
plasmid pcDNA3 (Invitrogen), where its expression is driven by the
CMV promoter. This construct, and a control lacking the insert,
were stably transfected into EMC cells (Eid et al., 1992) by calcium
phosphate followed by selection in 250 g/ml G418 for 2 weeks.
Stable colonies were individually picked and expanded. The domi-
nant negative subline EMCdn was chosen for use on the basis of
expression of the full-length RAR303E sequence.
To prepare conditioned media, cells were grown in the presence
of serum to near confluency, and then switched to DMEM alone for
1 day. The media was then replaced with fresh DMEM, retinoids
[all-trans retinoic acid at 106 M; the retinoid receptor antagonist
AGN193109 (Agarwal et al., 1996) at 107 M (kindly provided by R.
Chandraratna, Allergan Pharmaceuticals)] or solvent were added,
and the cells were cultured 2 more days before the conditioned
media was collected. Heat treatment of conditioned media was at
65°C for 30 min.
Cardiomyocyte Proliferation Assay
Ventricular tissue was isolated from either E13.5 mouse or E7
chick embryos, or at other stages as indicated in the text. Following
serial enzymatic digestion with collagenase (0.5 mg/ml for mouse;
0.44 mg/ml for chick) and pancreatin (1 mg/ml for mouse; 0.44
mg/ml for chick), the cell suspension was diluted with ADS buffer
(1  ADS buffer  116 mM NaCl, 20 mM Hepes, pH 7.3, 1 mM
NaH2PO4, 5.36 mM KCl, 0.83 mM MgSO4, 0.1% dextrose), and
layered on top of a Percoll step gradient. The bottom layer of this
gradient contained a 4:1 ratio of Percoll stock [90% Percoll (Amer-
sham-Pharmacia)  10% 10 ADS buffer]: 1  ADS buffer; the top
layer contained a 9:11 ratio for E12.5–E15.5 mouse cells, a 19:21
ratio for E16.5–E18.5 mouse cells, a 1:1 ratio for cells from newborn
to 3-day-old mouse pups, and a 17:23 ratio for chick heart cells. The
step gradients were spun at 3000 rpm for 30 min, and cardiomyo-
cytes were collected at the interface above the bottom layer. Using
this method, we were able to routinely obtain cardiomyocytes with
98% purity (assessed by MF20 immunostaining). After purifica-
tion, cardiomyocytes were plated on gelatin-coated 48-well dishes
in plating media (4:1 DMEM/M199 5% FBS 10% horse serum).
After 24 h, the media was replaced with serum-free DMEM, and the
cells were cultured for another 24 h. Thereafter, the media was
replaced with fresh DMEM or with serum-free conditioned media,
and 0.5 Ci [3H]thymidine was added per well. When used,
genistein was added to cardiomyocyte cultures at a concentration
of 30 M. After 48 h of incorporation, cells were washed three
times with ice-cold PBS, fixed with ice-cold 10% TCA, and lysed in
1 N NaOH. Cell lysates were pH neutralized with 1 N acetic acid
and transferred into scintillation vials to count radioactivity. A
background subtraction (generally 50–100 cpm) was calculated for
each experiment, measured by adding [3H]-thymidine to cells
cultured in DMEM alone 5 min before extraction. All data points
represent at least duplicate samples when mouse cardiomyocytes
were used, and at least quadruplicate samples when chick cardio-
myocytes or NIH3T3 cells were used.
NIH3T3 Cell Culture
NIH3T3 cells were grown in DMEM/10% FBS, then switched to
DMEM alone for 24 hr before replacement of media with fresh
DMEM or with epicardial cell-conditioned media. Thymidine
incorporation was exactly as above. For assessment of cell cycle by
flow cytometry, cells were isolated by trypsinization, washed, and
fixed overnight in 70% ethanol. Fixed cells were washed, and
incubated with 100 g/ml RNase and 20 g/ml propidium iodide
for 30 min at room temperature in the dark. For each sample, 104
cells were analyzed on an Epics XL/MCL flow cytometer (Beckman
Coulter).
Cyclin Immunodetection Assays
Cells were washed three times with PBS and solubilized by
rocking at 4°C for 30 min in lysis buffer (20 mM Tris, pH 8.0, 1%
NP40, 137 mM NaCl, 10 mM EDTA, 2 mM CaCl2, 1 mM MgCl2,
10% glycerol, 1 mM DTT, 1 mM PMSF, 2 mM Na3VO4, 10 mM
NaF, 10 mM Na4P2O4, 1 g/ml leupeptin, 1 g/ml aprotinin).
Following microcentrifugation for 20 min at 15,000g, the superna-
tant was assayed for protein content. For Western blotting, cell
lysates were resolved by 10% SDS-PAGE (Coomassie-stained gels
of parallel aliquots confirmed equal protein loading), followed by
electrophoretic transfer onto Immun-Blot PVDF membranes (Bio-
Rad). The membranes were then probed with anti-cyclin D1
(1:2000) or anti-cyclin E (1:2000) antibodies (Santa Cruz Biotech-
nology). After secondary incubation with an HRP-conjugated anti-
body, the signal was detected by using enhanced chemilumines-
cence (ECL) reagents.
RESULTS
As described above, the hypoplastic ventricular chamber
phenotype seen in RXR/ embryos does not represent a
role of RXR in the myocardium. To explore the potential
involvement of RXR in the endocardial and endothelial
cell lineages, we employed chimera technology. We have
previously demonstrated that ES cells lacking RXR, when
introduced into wild type recipient blastocysts, can contrib-
ute to all cell types of the developing heart in the resulting
chimeric embryos, including the endothelium (Tran and
Sucov, 1998). In contrast, other studies have shown that
absence of the Flk1 gene prevents formation of the endo-
thelial and endocardial lineages and causes embryo lethal-
ity at E9.5. This is a cell-autonomous phenotype, since only
Flk1-positive cells can form endothelium in chimeric em-
bryos (Shalaby et al., 1997). We therefore introduced
RXR/ ES cells into blastocysts derived from crosses of
Flk1/ parents. We examined all chimeric embryos at
E14.5 and recovered two embryos in which the RXR/ ES
cells had been introduced into Flk1/ blastocysts (as deter-
mined by retrospective genotyping). In such chimeric em-
bryos, the endothelial and endocardial cells must be derived
from the RXR/ ES cells. Both embryos were viable and
normal upon isolation, and histology did not reveal any
obvious deficiency in ventricular chamber morphogenesis
(data not shown). To address the possible function of RXR
in the neural crest lineage, we crossed a conditional
(“floxed”) allele of RXR (Chen et al., 1998) against the
Wnt1-cre transgene, which we have previously demon-
strated drives highly efficient recombination in the neural
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crest lineage beginning from the time that these cells are
derived from the dorsal neural tube (Jiang et al., 2000). In all
of several [Wnt1-cre, RXRf1/f1] embryos isolated at E14.5 or
later, ventricular chamber morphogenesis was normal, and
these embryos were viable at least to full term (data not
shown; see also Jiang et al., 2002). Thus, when the entire
neural crest cell or endothelial cell lineage of an embryo is
constituted by cells deficient in RXR, normal ventricular
morphogenesis still ensues.
We then turned our attention to the epicardial cell
lineage. The epicardium (although not epicardial-derived
mesenchymal cells) is positive for expression of EndoB (the
mouse form of human keratin 18) in vivo, and a human
keratin 18 (K18) promoter/enhancer construct has previ-
ously been shown to be expressed in the epicardium of
transgenic mouse embryos, as well as in other K18-positive
tissues outside of the heart (Thorey et al., 1993). We used
this promoter to drive expression of a dominant negative
RAR construct (RAR303E), which has been previously used
to induce phenotypes in skin and skeletal tissue when
expressed by appropriate promoters in transgenic embryos
(Saitou et al., 1995; Yamaguchi et al., 1998). Fertilized eggs
were injected with the K18-RAR303E construct, implanted
into recipient females, and the embryos then isolated at
E14.5. Of 21 recovered embryos, 6 were visibly edematous
upon isolation (Fig. 1), and only these 6 embryos were
positive for the transgene construct upon genotyping. Pe-
ripheral edema is a typical sign of fetal cardiac insuffi-
ciency, and is seen in RXR/ embryos at the same stage
(Fig. 1c). Histology of these transgenic embryos revealed a
ventricular chamber hypoplastic phenotype (thin compact
zone, and poorly formed ventricular septum) that strikingly
replicated what is seen in RXR/ embryos (Fig. 1),
whereas all nontransgenic littermate embryos exhibited
normal ventricular morphology. In transgenic embryos, as
in conventional RXR/ embryos, the epicardial-derived
FIG. 1. Transgenic expression of K18-RAR303E recapitulates the RXR/ cardiac phenotype. Shown are images of embryos and sections of a
nontransgenic embryo (a, d, g), a K18-RAR303E transgenic (b, e, h), and a conventional RXR-deficient embryo (c, f, i). The nontransgenic and
transgenic embryos are littermates; all embryos were isolated at E14.5. (a–c) Whole-mount views of isolated embryos. Note the peripheral edema
(indicated by an asterisk) in the transgenic (b) and knockout (c) embryos, which is suggestive of cardiac insufficiency; note also the presence of
an eye defect in knockout embryos (Kastner et al., 1994), which is not replicated by K18-RAR303E transgenic embryos. (d–f) Sections through the
heart, taken at a level close to the aortic (Ao) valve. Note in both transgenic and knockout embryos the hypoplastic ventricular chamber wall,
poorly formed ventricular septum, and interventricular septal defect (VSD). (g–i) High magnification views of the right ventricular chamber wall
(same magnification in each panel). Note the thinner compact zone (cz) of the transgenic and mutant embryos, and the normal presence of
forming coronary artery blood vessels (bv). Epi, epicardium; t, trabecular myocardium.
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mesenchyme still forms and nascent coronary arteries are
apparent in the hypoplastic ventricular chamber wall. This
indicates that epicardial expression of the dominant nega-
tive receptor does not interfere with formation of
epicardial-derived cells, and because epicardial-derived cells
do not express cytokeratins (including K18; Thorey et al.,
1993), this suggests that defects in the epicardial-derived
mesenchymal population are unlikely to account for the
phenotype of RXR/ hearts. We therefore conclude that
interference in retinoid receptor function within the do-
main of expression of the K18 transgenic promoter is
sufficient to induce the ventricular hypoplastic phenotype,
and because the epicardium is one such site, we suggest
that the site of action of retinoid receptors during heart
development is in the epicardium.
To further explore this model, we established an in vitro
assay to explore the proliferative behavior of fetal cardio-
myocytes. We isolated wild type primary fetal cardiomyo-
cytes to 98% purity from either E12.5–E13.5 mouse
embryos or E7 chick embryos, plated these cells overnight
in the presence of serum to promote attachment, further
cultured in serum-free media for 24 h, and then cultured for
an additional 48 h in the presence of [3H]thymidine. Cardi-
omyocytes cultured without any additional factors in the
media have a modest basal level of thymidine incorpora-
tion, whereas treatment of these cells with serum induces a
substantial increase in incorporation of the label (Fig. 2).
Treatment of cardiomyocytes with retinoic acid did not
have any proliferative effect (data not shown). We then
exposed cardiomyocyte cultures to serum-free conditioned
media prepared from a variety of sources. As a negative
control, conditioned media from HeLa cells, whether un-
treated or treated with retinoic acid, had no activity in this
assay (Fig. 2a).
We next isolated primary epicardial cells from individual
midgestation mouse embryos isolated from crosses of
RXR/ parents. Such cells can be expanded for at least
several passages in culture and retain their epithelial mor-
FIG. 2. Retinoic acid- and retinoid receptor-dependent induction of cardiomyocyte trophic activity in epicardial cells. All panels represent
results of tritiated thymidine incorporation in cultured chick cardiomyocytes exposed to serum-free DMEM media (SF), DMEM plus 10%
FBS (S), or to serum-free conditioned media as indicated. All data points were done in quadruplicate, and the ordinate axis for all panels
represents CPM incorporated. (a) Establishment of baseline conditions for the assay. HeLa cells, whether untreated () or retinoic acid
treated (RA; at 106 M), produce no activity in conditioned media that is trophic for cardiomyocytes. (b) Positive activity from wildtype (WT)
but not RXR/ (KO) primary epicardial cells. Wild type cells express a relatively high basal level of activity in the absence of treatment,
whereas RXR-deficient epicardial cells express little or no activity even following RA treatment. (c) Positive activity from EMC cells is
RA-inducible and is suppressed by exposure to the retinoid receptor antagonist AGN193109 (An; 10 M). (d) Normal expression of activity
in parental epicardial cells (EMC) and in a control subline (EMCc), and suppression of basal and inducible activity in EMC cells
constitutively expressing a dominant negative retinoic acid receptor construct (EMCdn). (e) The activity present in conditioned media from
EMC cells treated with RA is sensitive to heat inactivation (heat). (f) Genistein (Gen; 30 M) inhibits the proliferative response of
cardiomyocytes exposed to conditioned media from EMC cells.
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phology (Figs. 3a and 3b). These cells express several epi-
cardial markers and do not express markers of cardiac
muscle or endocardium (Fig. 3c, and data not shown).
Unlike our observations with HeLa cells, when conditioned
media was prepared from wild type primary epicardial cells,
a relatively high basal level of trophic activity on cardio-
myocytes was observed (Fig. 2b). This level of activity was
increased when the epicardial cells were treated with reti-
noic acid; because the incorporation of tritiated thymidine
by cardiomyocytes is saturable, the increased activity in-
duced by RA is not apparent in the experiment shown in
Fig. 2b, although serial dilution indicated a two- to three-
fold increase in activity caused by RA treatment of the
epicardial cells (data not shown). The high basal level
probably reflects endogenous production of retinoic acid,
since these cells express the RA synthetic enzyme RALDH2
(Fig. 3c), as do epicardial cells in vivo (Moss et al., 1998), and
because the basal activity could be suppressed by treatment
with a retinoid receptor antagonist (data not shown; see
below). Importantly, epicardial cells derived from RXR/
embryos produced little or no trophic activity into condi-
tioned media, either basally or when treated with retinoic
acid. Thus, the essential feature of the hypoproliferative
ventricular chamber in RXR/ embryos is replicated by
RXR/ epicardial cells in this in vitro assay of cardiomy-
ocyte proliferation.
A stable rat epicardial cell line, called EMC, has previ-
ously been derived (Eid et al., 1992, 1994). These cells
express RALDH2 and other markers of the fetal epicardium
(data not shown), similar to the primary fetal epicardial
cells described above. We next determined whether EMC
cells also secreted activity into conditioned media that
would be trophic for primary fetal cardiomyocytes. Indeed,
in a manner comparable to the activity of primary mouse
epicardial cells, EMC cells produced a relatively high basal
level of trophic activity, which could be further induced by
treatment with retinoic acid, and which was suppressed by
treatment with a retinoid receptor antagonist (Fig. 2c). We
then derived a stable subline of these cells, in which the
RAR303E dominant negative receptor described above was
stably and constitutively expressed. This subline, desig-
nated EMCdn, and a control subline (EMCc) expressing an
irrelevant product, were tested for the production of trophic
activity in the cardiomyocyte proliferation assay. Indeed,
we found that forced expression of the dominant negative
RA receptor blocked the basal production of cardiomyocyte
trophic activity, and prevented the induction of activity in
response to RA treatment (Fig. 2d). The EMC and EMCdn
epicardial cell lines therefore behave in a manner compa-
rable to wild type and RXR/ primary epicardial cells,
respectively.
As part of an exploration of the biochemical properties of
the trophic factor(s) made by epicardial cells, we found that
the activity is abolished by heat treatment (Fig. 2e) and is
ammonium sulfate precipitatable (data not shown), both
suggestive of a protein or peptide. We also found that
treatment of cardiomyocytes with genistein, a tyrosine
kinase inhibitor, abolished their response to epicardial
cell-produced trophic stimulation, suggestive of the in-
volvement of a receptor tyrosine kinase or a cytoplasmic
tyrosine kinase in transducing this activity (Fig. 2f).
Most known cytokines and growth factors have activity
on multiple cells types. We found that conditioned media
from RA-treated EMC cells was also trophic for 3T3 cells,
assayed both by thymidine incorporation as well as by flow
cytometry (Figs. 4a and 4b). The response of 3T3 cells to the
epicardial cell-derived trophic activity involved the upregu-
lation of cyclin D1 and E expression (Fig. 4c), although for
lack of sufficient material we cannot yet say whether the
same or similar responses occur in primary fetal cardiomy-
ocytes. Nonetheless, these additional assays suggest that
the induction of thymidine incorporation in treated cells is
a true proliferative response to trophic factors present in
epicardial cell conditioned media.
FIG. 3. Derivation of primary epicardial cells. Cells from a wild type heart are shown, although cells from RXR/ hearts were identical
in all examined respects. (a) Initial outgrowth of epicardial cells after two days in culture. The large mass of cardiac tissue (indicated by the
asterisk) stays coherent in culture, whereas epicardial cells are seen migrating away from this mass. (b) Epithelial morphology of primary
epicardial cells. A morphologically uniform culture of epithelial cells is seen after removal of the cardiac tissue mass and after three
passages of the remaining epicardial cells. (c) Expression of appropriate molecular markers in primary epicardial cells. RNA was extracted
from whole heart tissue or from primary epicardial cells, and analyzed by RT-PCR for expression of epicardial markers (retinaldehyde
dehydrogenase 2, keratin 18, epicardin), cardiac muscle markers (cardiac actin, myosin light chain 2v, myosin heavy chain ), and
endocardial/endothelial markers (platelet endothelial cell adhesion molecule 1, Tie2). All markers are expressed in the mixed population
of the whole heart, whereas primary epicardial cells express only epicardial markers.
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Finally, we addressed how the production of and response
to trophic activity changes during development. We found
that conditioned media prepared from wild type mouse
epicardial cells derived from late gestation embryos was
comparably active to that produced by epicardial cells
derived from midgestation embryos (Fig. 5a). However,
epicardial cells obtained from early postnatal animals pro-
duced substantially less of the activity (although there was
still detectable activity made from these cells). Midgesta-
tion fetal atrial cardiomyocytes were comparably respon-
sive to stimulation as ventricular cardiomyocytes from
embryos of the same age (Fig. 5b). However, the ability of
cardiomyocytes to respond to stimulation decreases pro-
gressively as development proceeds, being highest in cells
isolated at the earliest developmental stages and falling off
as development proceeds. In the postnatal period, cardio-
myocytes isolated from newborn pups were only marginally
responsive to trophic stimulation, and cells isolated from
3-day-old pups were refractory to proliferation.
DISCUSSION
Based on the results described in this study, we propose
that the fetal epicardium secretes one or more protein
factors that stimulate fetal cardiomyocyte proliferation.
The production of this factor is induced by retinoic acid,
which is probably produced in an autocrine or paracrine
manner by epicardial expression of RALDH2, and this
induction requires the involvement of RXR. We propose
that the pathology seen in the hearts of RXR/ embryos
reflects a failure in the production of this activity and the
resulting lack of cardiomyocyte proliferation.
A prediction of this model is that ablation of the epicar-
dium should result in a hypoplastic ventricular chamber
wall. This appears to be the case in VCAM-1 (Gurtner et al.,
1995; Kwee et al., 1995) and possibly also 4 integrin (Yang
et al., 1995) mutant mice, where a physical interaction
between these two molecules is normally responsible for
adherence (and persistence) of the epicardium to the myo-
cardium. Similarly, in chick embryos, formation of the
epicardium can be partially prevented by the insertion of a
piece of egg shell membrane in front of the proepicardial
organ (the precursor of the epicardium). This results in patches
of absent epicardium, with the myocardium underneath be-
coming hypoplastic (Gittenberger-de Groot et al., 2000).
The existence of an epicardial proliferative signal ac-
counts for two aspects of fetal ventricular development that
FIG. 5. Changes in production of and response to trophic activity
during development. (a) Production of trophic activity in primary
wild type mouse epicardial cells isolated from embryos or pups at
various stages as indicated. Conditioned media was prepared from
RA-treated cultured primary epicardial cells and collected and
stored; all samples were assayed on chick cardiomyocytes in the
same experiment. Solvent-treated cells showed lower but propor-
tional levels of activity (not shown). Data is expressed as CPM of
tritiated thymidine incorporated. (b) Response of primary mouse
cardiomyocytes isolated from embryos or pups at the indicated
stages. All cardiomyocytes were treated with the same batch of
conditioned media from EMC cells treated with RA, although
because all assays were done at different times, the data is ex-
pressed in terms of fold induction caused by conditioned media
relative to the basal level of thymidine incorporation in cardiomy-
ocytes exposed only to serum-free DMEM. Cardiomyocytes were
prepared from ventricular (V) or atrial (A) tissue as indicated.
FIG. 4. Response of NIH3T3 cells to trophic stimulation by
conditioned media from RA-treated epicardial cells. (a) Thymidine
incorporation assay. Serum-free and serum controls are as in Fig. 2.
(b) Flow cytometry assay. Cells were cultured in serum-free media
supplemented with conditioned media from RA-treated EMC cells
for the indicated times, then propidium iodide-stained and passed
through a cell sorter. Cells were categorized as being in the resting
(G0 or G1) or cycling (S, G2, or M) phase of the cell cycle, based on
DNA content. (c) Expression of cyclin D1 and cyclin E is induced
by exposure to epicardial cell-conditioned media. Shown are West-
ern blots of equal levels of loaded protein (36 g) taken from cells
exposed to conditioned media [EMC(RA)] or 10% serum (S) for the
indicated times (in h).
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have previously been obscure. First, it has been noted that
cardiomyocyte proliferation is greater on the epicardial side
of the chamber wall than on the endocardial side, which is
suggestive of a proliferative signal originating from the
epicardium (Rumyantsev, 1977; Tokuyasu, 1990). Second,
the utilization of the epicardium as the source of a prolif-
erative signal provides a simple developmental mechanism
for coordinating the timing of ventricular chamber growth
and for formation of the compact layer of the ventricular
chamber wall, which in mouse embryos begins around
E10.5, immediately following formation of the epicardial
layer.
Previous studies have given rise to the suggestion that the
RXR/ cardiac phenotype may result indirectly from
placental dysfunction (Kastner et al., 1997; Sapin et al.,
1997). Our results are not incompatible with this model,
and in fact, the hypoplastic ventricular phenotype may
represent the combined effects of placental deficiency as
well as local epicardial deficiency. We cannot say at this
time which of these effects is more important in defining
the overall phenotype.
A number of reciprocal interactions occur between adja-
cent layers of the developing heart, mediated by secreted
factors. The myocardium secretes factors, including TGF3,
that act on the endocardium to induce an epithelial–mes-
enchymal transformation that allows endocardial-derived
cells to populate the atrioventricular and conotruncal cush-
ions (Brown et al., 1999; Runyan et al., 1992). Similarly, the
myocardium produces additional factors, including FGFs,
that act on the epicardium to induce an epithelial–
mesenchymal transformation that creates the vascular en-
dothelium of the coronary arteries, the smooth muscle cells
that surrounds these arteries, and the cardiac fibroblast
lineages (Morabito et al., 2001). In return, the endocardium
secretes neuregulin, which acts at the inner surface of the
myocardium to induce cardiomyocyte proliferation and
trabecular ingrowth (Gassmann et al., 1995; Lee et al., 1995;
Meyer and Birchmeier, 1995). Based on our observations, we
propose a fourth axis of signaling, in which factors secreted
by the epicardium act on the outer surface of the myocar-
dium to induce cardiomyocyte proliferation and compact
zone formation.
The identity of the factor (or factors) produced by the
epicardium in response to retinoic acid signaling is cur-
rently unknown. EMC cells are known to express endothe-
lins (Eid et al., 1994), but endothelin expression is not
retinoic acid regulated in these cells, and blocking antibod-
ies against endothelins do not suppress cardiomyocyte
proliferation induced by epicardial cell conditioned media
(unpublished observations). We have also explored the pos-
sibility that erythropoietin, which our prior work has
shown to be a primary target gene of retinoic acid and RA
receptor action (Makita et al., 2001), may be involved in the
cardiac defect of RXR/ embryos. However, erythropoi-
etin is expressed at only trace levels by epicardial cells, and
transgenic expression of erythropoietin in the fetal heart
from a  myosin heavy chain promoter does not rescue the
cardiac defects of RXR/ embryos (unpublished observa-
tions). We have also explored a number of additional can-
didate factors, including IGF1, midkine, PDGF, and several
others, but none of these appear to be regulated by retinoic
acid in epicardial cells. It is of course possible that retinoic
acid induces the expression of a processing enzyme that
acts on a constitutively expressed precursor to create an
active factor, although we currently have no evidence that
would support this model. We have initiated biochemical
and molecular strategies to identify the factors responsible
for the cardiomyocyte trophic response, to identify the
receptors of these factors, and to define the target genes that
are immediately retinoic acid regulated at the onset of this
process. These investigations may also help understand
why the atrial compartment does not undergo the prolifera-
tive expansion that occurs in the ventricular chamber in
vivo, even though atrial cardiomyocytes seems equally able
to respond to epicardial trophic stimulation in vitro (Fig. 4).
Possibly, the production of trophic factors by the epicar-
dium in vivo differs between the atrial and ventricular
chambers.
It has long been known that fetal cardiomyocytes prolif-
erate, whereas postnatal cardiomyocytes are mostly if not
completely postmitotic. Our results with cardiomyocytes
isolated from different developmental stages and exposed to
epicardial cell conditioned media indicate that the myocar-
dium itself changes over time in its ability to respond to
trophic stimulation. In fact, our results are most easily
explained by a stochastic loss of proliferative potential in
the cardiomyocyte population as development progresses.
This was previously understood based on the response of
fetal and postnatal cardiomyocytes to serum stimulation,
but our results represent a more biologically relevant con-
text from which to draw this conclusion. The identification
of the receptor of the epicardial trophic signal, which as
described above may be a member of the receptor tyrosine
kinase family, should enable the definition of the signaling
pathways which are triggered by trophic stimulation in
fetal cardiomyocytes, and the alterations in signal transduc-
tion that occur in postnatal cells that prevent a proliferative
response.
A number of mouse gene mutations result in a ventricu-
lar hypoplastic phenotype which is comparable if not iden-
tical to that of RXR deficiency (Rossant, 1996; Sucov,
1998). One of these, the N-myc gene product, acts cell
autonomously in fetal cardiomyocytes to support compact
zone formation, and we have previously shown that RXR
function is not epistatic to N-myc expression (i.e., myc
expression does not rescue the RXR/ phenotype) (Tran
and Sucov, 1998). A long-term goal of these studies is to
assemble a pathway of genetic control of cardiomyocyte
proliferation and compact zone morphogenesis. Our dem-
onstration of the epicardium as a critical source of trophic
stimulation, and the in vitro culture assays we have em-
ployed in this study, should facilitate the experimental
dissection of the roles of these other genes in these pro-
cesses.
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Ischemic heart disease is the leading cause of death in the
Western world and represents myocardial cell death caused
by coronary artery obstruction and the inability of adult
myocardium to repair itself via proliferation. Recent inves-
tigations have led to the conception that there may exist
cardiomyocyte stem cells, either within the heart or derived
from extracardiac sources, which to a limited extent may
initiate proliferation within the scar of ischemic damage
(Anversa and Nadal-Ginard, 2002). The factors described in
this study may be useful in stimulating such cells to further
or more rapidly divide, in a manner which could be thera-
peutically meaningful.
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